CDH2 and cervical squamous cell carcinoma: As per the survival analysis in cervical squamous cell carcinoma (CESC), CDH2 (N-cadherin) shows a significant overall survival association with a p-value of 0.0017 and a hazard ratio (HR) of 2.1, indicating its strong prognostic relevance in disease progression.